GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Outcome of AGM28-06-2024
GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of AGM28-06-2024
GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Closure of Trading Window
Trading window closure27-06-2024
GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Advance intimation under Regulation 3927-06-2024
New product launches may continue to fuel GSK Pharma's robust growth
GSK Pharma's recent good showing is on expectations that launches in the specialty segment, increasing investments in promotions and branding25-06-2024
GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Disclosure Under Regulations 30
Disclosure under Regulations 3025-06-2024
GSK Pharma - Business In Recovery Model: Motilal Oswal
Valuation adequately factors in the earnings upside24-06-2024
GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Advance intimation under Regulation 3924-06-2024
GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Disclosure Under Clause 30
Disclosure under clause 3020-06-2024
GLAXOSMITHKLINE PHARMACEUTICALS LTD. - 500660 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Advance intimation under Regulation 3919-06-2024